Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomark Diagnostics Inc (BUX.CN)

Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic CapabilitiesVancouver, British Columbia--(Newsfile Corp. - January...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark: 2025 Achievements & 2026 Vision

Celebrating A Year of Extraordinary AchievementVancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"),...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: BUX)...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE:...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala

Recognition of BioMark Leadership in Early Cancer Detection Validates Commercialization Trajectory of Multimodal Lung Cancer Screening PlatformVancouver, British Columbia--(Newsfile Corp. - December 1,...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy

Next-generation metabolomics and AI technology supports the 2026 - 2035 Pan-Canadian Lung Cancer Action Plan's call to expand equitable access to life-saving early diagnosisVancouver, British Columbia--(Newsfile...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
Upcoming Meeting Dates - October 20, 2025

Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

ENBI.CN : 0.1000 (unch)
RV.VN : 0.055 (unch)
SILV.VN : 0.290 (-6.45%)
FMM.VN : 0.065 (+30.00%)
ATHR.CN : 0.0250 (unch)
AJN.CN : 0.2300 (unch)
CTTT.CN : 0.4800 (+5.49%)
AUEN.VN : 0.330 (unch)
SVE.VN : 0.710 (+1.43%)
LA.VN : 14.500 (+2.47%)
BIRD.VN : 0.085 (-10.53%)
CMC.VN : 0.065 (-7.14%)
BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial

Extensive Validation of BioMark's Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.Vancouver,...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy

Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.Vancouver, British Columbia--(Newsfile Corp. -...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership

Proof-of-Concept Trial Opens Door to 90+ Million Population Across North Africa and Francophone MarketsVancouver, British Columbia--(Newsfile Corp. - August 12, 2025) - BioMark Diagnostics Inc. (CSE:...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)

Barchart Exclusives

Michael Burry Still Doesn’t Understand Google’s AI Spending. Should You Ditch GOOGL Stock Here?
As Alphabet goes all-in on AI, writing billion-dollar checks, Michael Burry waves a caution flag. Should investors stick around or pull back for now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar